Article
Single-cell transcriptomics and mouse model phenotyping for biomarker screen of peripheral blood in Huntington's disease.
Scientific reports - 26 May 2026
Martín-Climent Paula, Ortuño-Miquel Samanta, Gallego-Serna Juan F, Martí-Martínez Silvia, Valor Luis M
Abstract excerpt
Transcriptional dysregulation is among the most prominent molecular alterations in Huntington's disease (HD). It is not confined to the brain but also extends to peripheral tissues and cells, enabling minimally invasive screening strategies to identify transcriptional surrogates of the health status in HD mutation carriers. Nonetheless, transcriptomics approaches have failed to identify consistent candidates from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
